Endocrine dysfunction in impotence: incidence, significance and cost-effective screening

Area of Science:

• Endocrinology
• Urology
• Men's Health

Background:

• Erectile dysfunction (ED) evaluation often includes the hypothalamic-pituitary-gonadal axis.
• The prevalence and impact of hormonal issues in unselected impotent men are not well-defined.

Purpose of the Study:

• To determine the incidence and significance of hormonal abnormalities in men with erectile failure.
• To establish cost-effective endocrine screening protocols for impotence.

Main Methods:

• Systematic, multidisciplinary assessment of 256 men with erectile dysfunction.
• Categorization of etiology into organic, psychogenic, or mixed/uncertain.
• Evaluation of hypothalamic-pituitary-gonadal axis function.

Main Results:

• Organic etiology found in 35.9%, psychogenic in 38.3%, and mixed/uncertain in 25.8% of patients.
• Overall incidence of hormonal abnormalities was 17.5%, clearly contributing to ED in 12.1% of cases.
• Recommended cost-effective screening includes history, physical examination, and serum testosterone levels.

Conclusions:

• Endocrine evaluation is crucial in assessing erectile dysfunction.
• A targeted, cost-effective screening approach can identify relevant hormonal abnormalities.
• Advanced testing should be reserved for specific patient subgroups.